Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Acumen Pharmaceuticals (ABOS) stock

Learn how to easily invest in Acumen Pharmaceuticals stock.

Acumen Pharmaceuticals, Inc
NASDAQ: ABOS - USD
BIOTECHNOLOGY
$17.08
-$0.05 (-0.29%)

Acumen Pharmaceuticals, Inc is a biotechnology business based in the US. Acumen Pharmaceuticals shares (ABOS) are listed on the NASDAQ and all prices are listed in US Dollars. Acumen Pharmaceuticals employs 7 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Acumen Pharmaceuticals

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – ABOS – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Acumen Pharmaceuticals stock price (NASDAQ: ABOS)

Use our graph to track the performance of ABOS stocks over time.

Acumen Pharmaceuticals shares at a glance

Information last updated 2021-07-23.
52-week range$16.48 - $26.98
50-day moving average $18.59
200-day moving average $18.59
Wall St. target priceN/A
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) N/A

Buy Acumen Pharmaceuticals shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $3.00 and $300 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
Download and sign up with Public.com; approved accounts receive a free stock slice worth up to $70, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.
Robinhood
$0
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Moomoo
$0 for US stocks
Stocks, Options, ETFs
$0
$0 per year
N/A
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Acumen Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Acumen Pharmaceuticals financials

Revenue TTM $1.2 million
Gross profit TTM $-6,561,000
Return on assets TTM 0%
Return on equity TTM 0%
Profit margin 0%
Book value N/A
Market capitalisation $660.2 million

TTM: trailing 12 months

Acumen Pharmaceuticals share dividends

We're not expecting Acumen Pharmaceuticals to pay a dividend over the next 12 months.

Acumen Pharmaceuticals overview

Acumen Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, engages in the development of therapeutics for the treatment of Alzheimer's and other neurodegenerative diseases. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, which is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is based in Charlottesville, Virginia. .

Frequently asked questions

What percentage of Acumen Pharmaceuticals is owned by insiders or institutions?
Currently 12.336% of Acumen Pharmaceuticals shares are held by insiders and 49.643% by institutions.
How many people work for Acumen Pharmaceuticals?
Latest data suggests 7 work at Acumen Pharmaceuticals.
When does the fiscal year end for Acumen Pharmaceuticals?
Acumen Pharmaceuticals's fiscal year ends in December.
Where is Acumen Pharmaceuticals based?
Acumen Pharmaceuticals's address is: 427 Park St., Charlottesville, VA, United States, 22902

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site